MarketPeel
Insider Trading Intelligence
Pricing
…
AE

Anthony George Evers

SURG
CHIEF FINANCIAL OFFICER · SURGEPAYS, INC. · CIK 0001828251
FILING MIX · LIFETIME63%/37%
BUYS
17
SELLS
10
TOTAL VALUE
$420.4K
COMPANIES
1
ACTIVE SINCE
Oct 2020
HOLDINGS NOW
414,924
AVG SELL PX
$1.97
TRADE KIND
SHOWING 27 / 27
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
17 backtested trades · 8 horizons · 8 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Anthony George Evers, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d17+35.29%+0.82%+1.13%-0.31%-4.19%—
14d17+64.71%+6.76%+2.79%+3.97%+10.51%—
30d17+82.35%+23.50%+4.01%+19.49%+10.54%—
60d17+76.47%+4.93%+6.47%-1.54%+7.36%—
90d17+82.35%+2.48%+8.96%-6.49%+11.04%—
180d17+82.35%+44.49%+13.52%+30.97%+49.59%—
1y17+58.82%+20.90%+25.50%-4.60%-16.24%—
2y17(8 pending)+88.89%-5.54%+21.60%-27.15%-2.62%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SURG · 414,924 shares · as of Dec 31, 2025
0103,731207,462311,193414,92420212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
FLOW · 17 buys / 10 sellsCOVERAGE · 21 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SURG
SURGEPAYS, INC.
PURCHASEGRANT
Stock grant
200,000——414,924Dec 31, 2025Jan 5, 2026 ↗View →
SURG
SURGEPAYS, INC.
SALE
Chief Financial Officer
36,666$1.86$68.2K214,924Dec 2, 2024Dec 4, 2024 ↗View →
SURG
SURGEPAYS, INC.
SALE
Chief Financial Officer
36,667$1.60$58.7K251,590Nov 1, 2024Nov 15, 2024 ↗View →
SURG
SURGEPAYS, INC.
SALE
Chief Financial Officer
36,667$1.54$56.4K288,257Oct 2, 2024Oct 3, 2024 ↗View →
SURG
SURGEPAYS, INC.
PURCHASEGRANT
Stock grant
66,667——324,924Oct 1, 2024Oct 3, 2024 ↗View →
SURG
SURGEPAYS, INC.
SALE
Chief Financial Officer
3,333$1.46$4.9K258,257Sep 4, 2024Sep 3, 2024 ↗View →
SURG
SURGEPAYS, INC.
SALE
Chief Financial Officer
33,334$1.54$51.3K261,590Sep 3, 2024Sep 3, 2024 ↗View →
SURG
SURGEPAYS, INC.
PURCHASEGRANT
Stock grant
66,667——294,924Sep 1, 2024Sep 3, 2024 ↗View →
SURG
SURGEPAYS, INC.
SALE
Chief Financial Officer
8,333$2.78$23.2K228,257Aug 1, 2024Aug 5, 2024 ↗View →
SURG
SURGEPAYS, INC.
PURCHASEGRANT
Stock grant
66,667——236,590Aug 1, 2024Aug 5, 2024 ↗View →
SURG
SURGEPAYS, INC.
SALE
Chief Financial Officer
83$3.00$249169,923Jul 31, 2024Aug 5, 2024 ↗View →
SURG
SURGEPAYS, INC.
SALE
Chief Financial Officer
2,000$3.00$6.0K170,006Jul 15, 2024Jul 16, 2024 ↗View →
SURG
SURGEPAYS, INC.
SALE
Chief Financial Officer
2,000$3.00$6.0K172,006Jul 11, 2024Jul 12, 2024 ↗View →
SURG
SURGEPAYS, INC.
SALE
Chief Financial Officer
36,667$3.01$110.3K174,006Jul 3, 2024Jul 3, 2024 ↗View →
SURG
SURGEPAYS, INC.
PURCHASEGRANT
Stock grant
66,667——210,673Jul 1, 2024Jul 3, 2024 ↗View →
SURG
SURGEPAYS, INC.
PURCHASEGRANT
Stock grant
66,667——144,006Jun 1, 2024Jun 3, 2024 ↗View →
SURG
SURGEPAYS, INC.
PURCHASEGRANT
Stock grant
66,667——77,339May 1, 2024May 3, 2024 ↗View →
SURG
SURGEPAYS, INC.
PURCHASE
CHIEF FINANCIAL OFFICER
36,949$0.08$3.0K363,549Nov 2, 2020Nov 3, 2020 ↗View →
SURG
SURGEPAYS, INC.
PURCHASE
CHIEF FINANCIAL OFFICER
5,000$0.09$445326,600Oct 30, 2020Nov 2, 2020 ↗View →
SURG
SURGEPAYS, INC.
PURCHASE
CHIEF FINANCIAL OFFICER
5,000$0.09$469321,600Oct 29, 2020Nov 2, 2020 ↗View →
SURG
SURGEPAYS, INC.
PURCHASE
CHIEF FINANCIAL OFFICER
5,000$0.10$475316,600Oct 28, 2020Oct 30, 2020 ↗View →
SURG
SURGEPAYS, INC.
PURCHASE
CHIEF FINANCIAL OFFICER
50,000$0.10$5.0K311,600Oct 27, 2020Oct 29, 2020 ↗View →
SURG
SURGEPAYS, INC.
PURCHASE
CHIEF FINANCIAL OFFICER
50,000$0.10$5.0K261,600Oct 26, 2020Oct 28, 2020 ↗View →
SURG
SURGEPAYS, INC.
PURCHASE
CHIEF FINANCIAL OFFICER
9,100$0.10$910211,600Oct 20, 2020Oct 22, 2020 ↗View →
SURG
SURGEPAYS, INC.
PURCHASEGRANT
Stock grant
50,000$0.10$5.0K202,500Oct 14, 2020Oct 15, 2020 ↗View →
SURG
SURGEPAYS, INC.
PURCHASEGRANT
Stock grant
50,000$0.10$5.0K152,500Oct 13, 2020Oct 15, 2020 ↗View →
SURG
SURGEPAYS, INC.
PURCHASEGRANT
Stock grant
100,000$0.10$10.0K102,500Oct 12, 2020Oct 15, 2020 ↗View →
Other insiders · SURG
Loading peer insiders…
About this filer
CIK 0001828251
ROLE
Chief Financial Officer
PRIMARY
SURG
COMPANIES
1
ACTIVE SINCE
Oct 2020
MARKETPEEL · /INSIDER/0001828251DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback